BGC0222

Ref. TM-T203374

10mg

To inquire

50mg

To inquire

Product Information

Name:BGC0222

Brand:Targetmol

Description:BGC0222 is a novel Irinotecan prodrug. As a PEG-cRGD conjugated derivative of Irinotecan, BGC0222 enables the slow and steady release of Irinotecan. It binds to the αVβ3 target with an IC50 of 4.25 μM and has an IC50 of 58.7 μM for αVβ5. BGC0222 can induce angiogenesis and demonstrates significant antitumor activity in various tumors.

Notice:Our products are intended for lab use only. For any other use, please contact us.

Chemical properties

Molecular weight:26927.36

Formula:C₁₂₄₁H₂₂₇₆N₆₄O₅₅₂

Technical inquiry about: BGC0222

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.